Proteome Sciences plc (AIM:PRM)
London · Delayed Price · Currency is GBP · Price in GBX 3.235
-0.075 (-2.27%)
Sep 9, 2025, 11:31 AM GMT+1
Proteome Sciences Market Cap
Proteome Sciences has a market cap or net worth of 9.77 million as of September 9, 2025. Its market cap has decreased by -5.43% in one year.
Market Cap
9.77M
Enterprise Value
23.16M
Revenue
4.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.24
Market Cap Chart
Since September 17, 1997, Proteome Sciences's market cap has decreased from 27.59M to 9.77M, a decrease of -64.58%. That is a compound annual growth rate of -3.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 9.77M | -2.65% |
| Dec 31, 2024 | 10.04M | -24.94% |
| Dec 29, 2023 | 13.37M | 29.43% |
| Dec 30, 2022 | 10.33M | -31.71% |
| Dec 31, 2021 | 15.13M | 32.43% |
| Dec 31, 2020 | 11.42M | 31.63% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 185.62B |
| GSK plc | 58.98B |
| Haleon | 32.14B |
| Smith & Nephew | 12.27B |
| ConvaTec Group | 4.86B |
| Hikma Pharmaceuticals | 3.76B |
| HUTCHMED (China) | 1.98B |
| Genus | 1.75B |